Integration of AI with Metabolomics and Launch of New Products to Augment Growth of Metabolomics Market

 


Launch of new products is expected to propel growth of the metabolomics
market. For instance, in January 2021, JUNO Metabolomics launched the JUNO
Viral Surveillance Platform based on its proprietary AI-Based Informatics
System. Similarly, in June 2019, Bruker Corp. presented mass spectrometry and
Nuclear Magnetic Resonance systems and other solutions for molecular phenomics
and clinical metabolomics research at Metabolomics 2019. Moreover, increasing
prevalence of chronic disorders is also expected to aid in growth of the market.
For instance, according to the American Cancer Society, in 2019, there will be
an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in
the U.S.



Integration of Artificial Intelligence (AI) with metabolomics
is expected to offer lucrative growth opportunities for players
in the metabolomics market. For instance, in July 2020, ReviveMed, an AI-driven
drug discovery platform, collaborated with Bristol Myers Squibb for an
AI-driven metabolomics study that will leverage ReviveMed’s AI platform to
better understand mechanisms of response and resistance to immunotherapies in
patients with cancer. Moroever, increasing demand for metabolomics is also
expected to aid in growth of the market. For instance, in August 2020, Metabolon
signed a multiyear drug development alliance with Germany's Merck KGaA. Metabolon
will apply its Precision Metabolomics liquid chromatography-mass spectrometry
global metabolomics platform to undisclosed early-stage drug development
programs across therapeutic areas at Merck.



However, low adoption of metabolomics in cell therapy
manufacturing and preference for traditional tools is expected to hinder growth
of the metabolomics market.



Competitive Landscape



Major players operating the metabolomics market include,
Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Biocrates Life
Sciences AG, JUNO Metabolomics, Shimadzu Corporation, Waters Corporation, Human
Metabolome Technologies, Inc., LECO Corporation, Metabolon, Inc., Bio-Rad
Laboratories, Inc., EluciData, and Bruker Corporation.



Major players operating the metabolomics market are focused
on adopting collaboration and partnership strategies Major players operating
the metabolomics market. For instance, in June 2020, Metabolon, Inc. collaborated
with DNA Genotek, a subsidiary of OraSure Technologies, Inc., for the
development of OMNImet GUT, the first device for in-home collection and
ambient-temperature storage and shipping of fecal samples for metabolomics.



Similarly, in June 2019, SCIEX entered into a co-marketing
agreement with EluciData, an India-based integrated omics platform company, under
which EluciData and SCIEX will promote EluciData’s integrated omics platform,
called Polly, in conjunction with SCIEX technologies, including TripleTOF, X500R
QTOF and QTRAP, as well as differential ion mobility technology.

Comments

Post a Comment

Popular posts from this blog

The Global Gynecological Devices Market Continues To Grow Owing To The Rising Demand For Regular Gynecological Checkups And Increasing Awareness On Women’s Health And Hygiene

Image
  A gynecological device is a medical device that is used to promote female health or to protect and preserve reproductive health for females. This is a very broad category and includes products such as watches, calculators, bandages, and hygienic towels. While many of these products have been clinically tested and found to be safe for female health, there are still a few devices in the market that pose threats to female reproductive health. Gynecological devices are usually fall into three categories: medical devices, biological safety devices, and mechanical devices. Medical devices are those that prevent the risk of injury or trauma to a woman's reproductive organs from medical interventions. Biologic safety devices are those that protect a female's health by promoting female reproductive health. Finally, mechanical devices are those that help maintain a woman's reproductive health and allow her to achieve or reach their desired fertility or pregnancy. The use of any of ...
Read more

Polyethylene Terephthalate Market Continues to Expand as British Petroleum plc signs a cooperation agreement with China Resources Chemical Materials Technology Co. Ltd to strengthen cooperation on PTA sourcing

Image
  PET is an abbreviation for polyethylene terephthalate; the material most often used in PET bottles. PET is an extremely tough plastic, which is why it's commonly used as a packaging material. PET has many advantages over other plastics, including strength, resistance to breaking and crushing, and its natural plasticity it will fill almost anything and is resistant to oil and chemicals that can cause it to break down over time. Rapid growth of the food and beverage industry is expected to drive of the global polyethylene terephthalate market growth . The food and beverage industry has witnessed significant growth in both developed and emerging economies. According to the Food and Drink Federation, the U.K., the food and drink manufacturing sector accounts for 17% in terms of economic contribution. Furthermore, according to the India Brand Equity Foundation (IBEF), the food processing industry contributed 14% of the country’s GDP in 2016. Polyethylene terephthalate or PET is widely...
Read more

Stomach Cancer Drugs Market Continues to Expand as South Korean Drug Manufacturer Celltrion Inc. Receives the WHO Prequalification Standards for its biosimilar

Image
  Stomach cancer is a growth of abnormal tissues that form a tumor in the part of your abdomen. Symptoms of stomach cancer often include persistent abdominal pain, extreme heartburn, extreme vomiting, severe indigestion, abdominal swelling, and frequent diarrhea. These symptoms are common for all forms of stomach cancer but when cancer spreads to the upper part of the chest, the symptoms become far more severe and may eventually cause death. Stomach cancer has the highest survival rate of any type of cancer in the world.  Crocetin (trade name Eulexin) is the first Stomach Cancer Drug that is used in the treatment of gastric cancer. It was later on approved for treating peritoneal mesothelioma but was not marketed extensively due to its negative outcomes at the beginning. Increasing prevalence of stomach cancer is expected to drive growth of the global stomach cancer drugs market during the forecast period. According to the American Cancer Society (ACS), in 2020, around 27,600...
Read more